Singh Vimal Kishor, Saini Abhishek, Kalsan Manisha, Kumar Neeraj, Chandra Ramesh
Stem Cell Research Laboratory, Department of Biotechnology, Delhi Technological University, Delhi, India.
Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, India.
J Stem Cells. 2016;11(3):149-169.
erythropoiesis methods are being developed for more than a decade now, and all the distinct types of stem cells (such as CD34 HSCs, ESCs, IPSCs, and extensively proliferating erythropoietic progenitor cells) are defined to bear the potential for large scale RBC production shortly. The various regulating factors at different levels of RBCs production are being explored. Since most of the ex-vivo erythropoiesis protocols mimic the dogma followed by hematopoietic stem cells to give rise to mature RBCs which essentially deals with the intermediate stages of erythropoiesis such as burst forming unit-erythroid (BFU-E) and committed erythroid colony forming unit-erythroid (CFU-E). generation of erythroid progenitors (BFU-E/CFU-E) is essentially controlled by several factors including glucocorticoids, inflammation, and stress. Furthermore, regular production of functionally mature /transfusable units of RBCs is possible only through the coordinated regulation of terminal proliferation and differentiation of erythroid progenitors by external signals, such as erythropoietin, SCF, IL-3 and interaction to extracellular matrix protein(s) in a 3D culture system. We discuss these complex intracellular networks of coordinated factors and try to understand their molecular mechanism through gene regulation by transcription factors, and miRNAs that might be helpful in developing the optimal RBCs production protocols for commercial production.
红细胞生成方法的研发至今已有十多年,所有不同类型的干细胞(如CD34造血干细胞、胚胎干细胞、诱导多能干细胞以及大量增殖的红细胞生成祖细胞)都被确定在不久后具备大规模生产红细胞的潜力。人们正在探索红细胞生成不同水平上的各种调节因子。由于大多数体外红细胞生成方案都模仿造血干细胞产生成熟红细胞所遵循的原则,这主要涉及红细胞生成的中间阶段,如红系爆式集落形成单位(BFU-E)和定向红系集落形成单位(CFU-E)。红系祖细胞(BFU-E/CFU-E)的生成基本上受多种因素控制,包括糖皮质激素、炎症和应激。此外,只有通过外部信号(如促红细胞生成素、干细胞因子、白细胞介素-3)对红系祖细胞终末增殖和分化的协调调节,以及在三维培养系统中与细胞外基质蛋白的相互作用,才有可能定期生产功能成熟/可用于输血的红细胞单位。我们讨论这些复杂的协调因子细胞内网络,并试图通过转录因子和微小RNA的基因调控来理解其分子机制,这可能有助于开发用于商业生产的最佳红细胞生产方案。